Changes in body fat measured by DEXA in patients taking different formulations of stavudine
Background: Lipoatrophy is a frequent complication of chronic stavudine therapy. Stavudine extended release formulation (stavudine ER) gives lower peak and higher trough levels than the immediate release formulation (stavudine IR), and we hypothesized that the lower peak might result in less lipoatr...
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Taylor and Francis Ltd.
2015
|
| Assuntos: | |
| Acesso em linha: | https://eprints.ums.edu.my/id/eprint/28984/1/Changes%20in%20body%20fat%20measured%20by%20DEXA%20in%20patients%20taking%20different%20formulations%20of%20stavudine%20ABSTRACT.pdf |